Tag: Cancer: Prostate
Higher Coffee Intake May Reduce Risk for Prostate Cancer
Pooled relative risk of 0.988 for each increment of one cup of coffee per day revealed in meta-analysis of cohort studies
FDA Approves First Oral Hormone Therapy for Advanced Prostate Cancer
Phase 3 trial data show 96.7 percent of patients who received Orgovyx achieved and maintained castrate levels of testosterone
Prostate Cancer Pathology Not Worse With Delayed Surgery
Delayed radical prostatectomy not linked to higher risk for adverse pathological outcomes in high-risk prostate cancer
Black Men Experience More Treatment Regret With Prostate Cancer
Higher medical mistrust and concerns about masculinity may contribute to regret
FDA Approves Drug for PET Imaging of Prostate Cancer
Approval of Gallium 68 PSMA-11 provides new imaging approach to detect prostate cancer metastasis or recurrence
Prognosis Good With Negative Biopsy in Active Surveillance
Negative biopsies during active surveillance for low-risk prostate cancer tied to more favorable outcomes
Cardiorespiratory Fitness Reduced With Prolonged ADT in Prostate Cancer
Increased cardiovascular mortality also seen with prolonged androgen deprivation therapy for prostate cancer
Biopsy Reclassification Risk in Prostate Cancer Examined
Gleason grade, prostate-specific antigen velocity, and imaging markers predict cancer spread
Higher Health Literacy Linked to Odds of PSA Screening
However, patients with higher health literacy less likely to undergo PSA screening in the presence of shared decision-making
Some Outcomes Worse for Black Men With Low-Risk Prostate Cancer
Ten-year cumulative incidence of disease progression, receipt of definitive treatment increased
